They do not show the weeks where nothing seemed to happen, the plateau at month two, the sudden drop at month three
Retatrutide is studied in research settings as a triple glucagon / GIP / GLP-1 receptor agonist, with interest in multi-incretin signaling, energy-expenditure models, food-intake models, glycemic endpoints, and body-composition research
Rockville: U.S
Journal of Clinical Medicine, 12(18), 5915
Sublingual drops are held under the tongue to allow absorption through mucous membranes, bypassing some gut metabolism
If you feel like your body isnt responding the way you expected, youre not alone and youre not doing anything wrong